Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for PSNL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -92.30M
March 31, 2026 -79.46M
December 31, 2025 -74.95M
September 30, 2025 -60.50M
June 30, 2025 -44.89M
March 31, 2025 -42.70M
December 31, 2024 -45.15M
September 30, 2024 -50.77M
June 30, 2024 -61.26M
March 31, 2024 -60.93M
December 31, 2023 -56.26M
September 30, 2023 -59.60M
June 30, 2023 -57.69M
March 31, 2023 -74.62M
December 31, 2022 -70.23M
September 30, 2022 -68.74M
Date Value
June 30, 2022 -71.86M
March 31, 2022 -70.44M
December 31, 2021 -70.83M
September 30, 2021 -58.09M
June 30, 2021 -56.33M
March 31, 2021 -45.75M
December 31, 2020 -42.65M
September 30, 2020 -37.72M
June 30, 2020 -31.23M
March 31, 2020 -26.78M
December 31, 2019 -18.07M
September 30, 2019 -17.27M
June 30, 2019 -8.064M
March 31, 2019 4.915M
December 31, 2018 5.572M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Tempus AI, Inc. -238.18M
10X Genomics, Inc. 127.08M
Alamar Biosciences, Inc. (California) -56.62M
Adaptive Biotechnologies Corp. -21.01M
Champions Oncology, Inc. -4.472M